AACR: As promised, new screening recommendations by the world’s leading LFS researchers are now published! Based on an international collaborative effort, researchers recommend a modified version of the “Toronto Protocol,” to include physical exams, blood tests, and imaging. They further recognize the need to evaluate the feasibility and effectiveness of surveillance and preventative strategies while
Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations By Florian T. Merkle, Sulagna Ghosh, Nolan Kamitaki, Jana Mitchell, Yishai Avior, Curtis Mello, Seva Kashin, Shila Mekhoubad, Dusko Ilic, Maura Charlton, Genevieve Saphier, Robert E. Handsaker, Giulio Genovese, Shiran Bar, Nissim Benvenisty, Steven A. McCarroll & Kevin Eggan This browser does not
Representatives of LFSA are attending Rare Disease Week in Washington DC with an exhibit at the National Institutes of Health (NIH) at their on-campus Rare Disease Day event to raise awareness for Li-Fraumeni Syndrome.
Our volunteer board members, Vice President Susan Faulkner (center left) and Co-Founder/Marketing Chair Debbie Soprano (center right), are at the National Society of Genetic Counselors Annual Education Conference in Seattle this week spreading awareness of LFS for you!! Go, Team LFSA!!!
Three Studies to Be Featured at the NSGC 35th Annual Education Conference SALT LAKE CITY, Sept. 26, 2016 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced it will present three new studies at the National Society of Genetic Counselors Annual Education Conference being held Sept. 28-Oct.